bpc-157 cream side effects Is Banned? Oral vs. Injectable Forms Explained What is BPC-157 and How

Recalls & Warnings April 20, 2026 FDA Warns Consumers Not to Use Certain Pain Relief Supplements On April 7, 2026, the FDA warned consumers not to purchase or use eight supplements labeled as containing hyaluronic acid and promoted for pain relief because they contain undeclared drugs

Third-party lab testing and a Certificate of Analysis (COA) are non-negotiable

Possible side effects include injection-site reactions, headache, nausea, and fatigue typically mild and resolving quickly

A 2026 consumer guide covering the best BPC-157 oral supplements, ingredient transparency, and purchasing considerations provides additional context on what to look for when comparing peptide supplement options